As an important indicator of nutrition and inflammatory state, the low expression of serum Alb is reported to be significantly associated with poor prognosis in various malignancies including prostate cancer [20], lung cancer [21], breast cancer [15] and chronic lymphocytic leukemia [22]. This evidence concerns the gene ALB and lung cancer.